TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,149 | +11.5% | 1,432 | +13.2% | 0.00% | 0.0% |
Q2 2023 | $19,873 | -31.4% | 1,265 | -28.0% | 0.00% | -50.0% |
Q1 2023 | $28,955 | +80.4% | 1,757 | +70.7% | 0.00% | +100.0% |
Q4 2022 | $16,052 | -62.7% | 1,029 | -69.0% | 0.00% | -80.0% |
Q3 2022 | $43,000 | -52.7% | 3,315 | -48.9% | 0.01% | -56.5% |
Q2 2022 | $91,000 | +355.0% | 6,490 | +357.0% | 0.02% | +360.0% |
Q1 2022 | $20,000 | +1900.0% | 1,420 | +1410.6% | 0.01% | – |
Q4 2021 | $1,000 | – | 94 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |